Health, Insurance Stocks Gain After Trump Administration Plans Higher Payments to Medicare Insurers
By Connor Hart
Shares of health and insurance companies rose after the Trump administration said it will raise payments to Medicare insurers by 2.48% next year.
UnitedHealth Group's stock climbed 6% in premarket trading Tuesday, to $298.26. Shares of Elevance Health were up 5.4%, to $319, while Humana increased 9.2%, to $199.50. CVS Health, which owns Aetna, was trading hands 6.7% higher, at $78.20.
The final 2027 rates for Medicare Advantage--the private-insurer version of the federal program for seniors and the disabled--marks a stark difference from preliminary proposals in January that called for roughly flat rates, which had drawn fierce criticism from the industry and torpedoed shares of the largest companies in the space.
Rates also came in ahead of some analysts' expectations, The Wall Street Journal reported. Several had suggested a rate increase would likely be finalized at around 1% or slightly higher, with a "bull" case closer to 2% to 3%.
The final increase represents about $13 billion in additional payments to the insurers, the Journal said.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
April 07, 2026 07:21 ET (11:21 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
United States